.png)
Summary
Data Protection: Addressing Noise, Speech, and Voice Concerns
Here's our newest conversation with Brij Mohan Lal Srivastava, CEO and Co-founder of Nijta, a company at the forefront of AI in speech anonymization. The realm of voice is an emerging and fascinating area within the life sciences, and with every new domain, issues of privacy come to the forefront.
In this discussion, we converse with Brij Mohan Lal Srivastava, who is the co-founder and CEO of Nijta, a company that focuses on developing AI-powered solutions for data anonymization and pseudonymization. These solutions are becoming increasingly important in clinical research, particularly with the emergence of voice as an important biomarker for identifying diseases such as depression. We delve into the fundamentals of noise, speech, and voice, and also explore how Nijta's technologies can be applied in the life sciences sector.
FAQs
Our frequently questions
Find out how iliomad can help your company.
Only visible in production
MR-001 CNIL: what clinical trial sponsors must know about French health data compliance
Understand MR-001 CNIL obligations for clinical trial sponsors in France, from Article 32 security requirements to breach notification and cross-border data transfers.
ICF Boilerplate and Open-Access Database Disclosures: What Clinical Trial Sponsors Must Know
Learn how US site ICF boilerplate on commercial products and open-access genetic databases affects sponsor data governance, Common Rule compliance and GDPR obligations.
iliomad Weekly Digest: DPO Conflicts, Bulk Data Rules, Healthcare Cyber Incidents and AI Transparency
This week: CNIL on DPO conflicts of interest, DOJ bulk data rule for life sciences, wave of healthcare ransomware attacks, Uber's €825m GDPR fine and AI disclosure demands.
